Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo

Ying Guo; Hui Yang; Shi Chen; Peng Zhang; Rong Li; Stephen D. Nimer; J. William Harbour; Mingjiang Xu; Feng Chun Yang

doi:10.1038/s41375-018-0126-9

Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo

Ying Guo, Hui Yang, Shi Chen, Peng Zhang, Rong Li, Stephen D. Nimer, J. William Harbour, Mingjiang Xu, Feng Chun Yang

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1834-1837
Number of pages	4
Journal	Leukemia
Volume	32
Issue number	8
DOIs	https://doi.org/10.1038/s41375-018-0126-9
State	Published - Aug 1 2018
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-018-0126-9

Cite this

@article{9ccb5b8ee006454e9fbda5807b769551,

title = "Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo",

author = "Ying Guo and Hui Yang and Shi Chen and Peng Zhang and Rong Li and Nimer, {Stephen D.} and Harbour, {J. William} and Mingjiang Xu and Yang, {Feng Chun}",

note = "Funding Information: Acknowledgements This work was supported by grants from the National Institutes of Health (CA172408 and CA185751 to F-CY and MX; CA125970 to JWH), National Heart, Lung, and Blood Institute (HL112294 to MX), and Leukemia and Lymphoma Society (F-CY, MX, and SDN). JWH was supported by Research to Prevent Blindness, Inc. Senior Scientific Investigator Award, Melanoma Research Alliance—Melanoma Research Foundation Established Investigator Award, Alcon Research Institute, and a generous gift from Dr. Mark J. Daily. The Bascom Palmer Eye Institute received funding from NIH Core Grant P30EY014801, Department of Defense Grant #W81XWH-13-1-0048, and a Research to Prevent Blindness Unrestricted Grant. We thank the services provided by the Satellite Histological Core of Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine.",

year = "2018",

month = aug,

day = "1",

doi = "10.1038/s41375-018-0126-9",

language = "English (US)",

volume = "32",

pages = "1834--1837",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo

AU - Guo, Ying

AU - Yang, Hui

AU - Chen, Shi

AU - Zhang, Peng

AU - Li, Rong

AU - Nimer, Stephen D.

AU - Harbour, J. William

AU - Xu, Mingjiang

AU - Yang, Feng Chun

N1 - Funding Information: Acknowledgements This work was supported by grants from the National Institutes of Health (CA172408 and CA185751 to F-CY and MX; CA125970 to JWH), National Heart, Lung, and Blood Institute (HL112294 to MX), and Leukemia and Lymphoma Society (F-CY, MX, and SDN). JWH was supported by Research to Prevent Blindness, Inc. Senior Scientific Investigator Award, Melanoma Research Alliance—Melanoma Research Foundation Established Investigator Award, Alcon Research Institute, and a generous gift from Dr. Mark J. Daily. The Bascom Palmer Eye Institute received funding from NIH Core Grant P30EY014801, Department of Defense Grant #W81XWH-13-1-0048, and a Research to Prevent Blindness Unrestricted Grant. We thank the services provided by the Satellite Histological Core of Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine.

PY - 2018/8/1

Y1 - 2018/8/1

UR - http://www.scopus.com/inward/record.url?scp=85046621541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046621541&partnerID=8YFLogxK

U2 - 10.1038/s41375-018-0126-9

DO - 10.1038/s41375-018-0126-9

M3 - Article

C2 - 29743720

AN - SCOPUS:85046621541

SN - 0887-6924

VL - 32

SP - 1834

EP - 1837

JO - Leukemia

JF - Leukemia

IS - 8

ER -

Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this